18F-fluoromisonidazole (FMISO) PET may have the potential to detect cardiac sarcoidosis

21Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

18F-fluoromisonidazole (FMISO) is a positron emission tomography (PET) tracer that accumulates in hypoxic tissues. We here present a case of suspected cardiac sarcoidosis which was detected with increased FMISO uptake.

Cite

CITATION STYLE

APA

Manabe, O., Hirata, K., Shozo, O., Shiga, T., Uchiyama, Y., Kobayashi, K., … Tamaki, N. (2017). 18F-fluoromisonidazole (FMISO) PET may have the potential to detect cardiac sarcoidosis. Journal of Nuclear Cardiology, 24(1), 329–331. https://doi.org/10.1007/s12350-016-0495-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free